Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 27 matching records.

Search the database

Evidence

Sort

27 results — page 1 of 2

Level DLaboratory StudyEurope PMC
Stem cell therapy alleviates hair loss caused by COVID-19 vaccination
Laboratory Study on Hair Loss, published in J Exerc Rehabil (2026) — summary generated from the PubMed abstract.
2026
J Exerc Rehabil
Level BClinical TrialEurope PMC
Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19
Clinical Trial with a reported sample of 19 on Chronic Inflammation, Immune Modulation, published in Mol Cell Biochem (2023) — summary generated from the PubMed abstract.
2023
Mol Cell Biochem
3 citations
n = 19
Level DNarrative ReviewEurope PMC
The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy
Narrative Review on Hip, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
2023
Stem Cell Res Ther
1 citations
Level ASystematic ReviewPubMed
Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19.
Systematic Review with a reported sample of 3 on Hair Loss, published in Regen Ther (2023) — summary generated from the PubMed abstract.
2023
Regen Ther
2 citations
n = 3
Level CProspective StudyPubMed
Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.
Prospective Study on Systemic / IV, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
2023
Stem Cell Res Ther
6 citations
Level DNarrative ReviewEurope PMC
Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19
Narrative Review with a reported sample of 19 on Neuroinflammation, published in Regen Eng Transl Med (2022) — summary generated from the PubMed abstract.
2022
Regen Eng Transl Med
n = 19
Level DNarrative ReviewEurope PMC
Stem cell therapy for COVID-19 pneumonia
Narrative Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Mol Biomed (2022) — summary generated from the PubMed abstract.
2022
Mol Biomed
4 citations
Level DNarrative ReviewEurope PMC
Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms
Narrative Review on Chronic Inflammation, Immune Modulation, published in Regen Ther (2022) — summary generated from the PubMed abstract.
2022
Regen Ther
8 citations
Level ASystematic ReviewEurope PMC
Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
Systematic Review with a reported sample of 19, published in Biomed Res Int (2022) — summary generated from the PubMed abstract.
2022
Biomed Res Int
5 citations
n = 19
Level ASystematic ReviewEurope PMC
Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review
Systematic Review with a reported sample of 19, published in World J Clin Cases (2022) — summary generated from the PubMed abstract.
2022
World J Clin Cases
4 citations
n = 19
Level DNarrative ReviewEurope PMC
Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19
Narrative Review on Immune Modulation, published in Biochim Biophys Acta Mol Basis Dis (2021) — summary generated from the PubMed abstract.
2021
Biochim Biophys Acta Mol Basis Dis
20 citations
Level CProspective StudyPubMed
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.
Prospective Study with a reported sample of 19 on Chronic Inflammation, published in Stem Cell Rev Rep (2021) — summary generated from the PubMed abstract.
2021
Stem Cell Rev Rep
n = 19
Level ASystematic ReviewEurope PMC
Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Systematic Review on Immune Modulation, published in Biomed Pharmacother (2021) — summary generated from the PubMed abstract.
2021
Biomed Pharmacother
17 citations
Level DNarrative ReviewEurope PMC
Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
Narrative Review on Chronic Inflammation, published in Stem Cells Int (2021) — summary generated from the PubMed abstract.
2021
Stem Cells Int
7 citations
Level DNarrative ReviewEurope PMC
Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury
Narrative Review with a reported sample of 19 on Cardiovascular Disease, published in Regen Ther (2021) — summary generated from the PubMed abstract.
2021
Regen Ther
4 citations
n = 19
Level ASystematic ReviewEurope PMC
Stem cell-based therapy for COVID-19 and ARDS: a systematic review
Systematic Review with a reported sample of 19, published in NPJ Regen Med (2021) — summary generated from the PubMed abstract.
2021
NPJ Regen Med
19 citations
n = 19
Level DNarrative ReviewEurope PMC
Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy
Narrative Review with a reported sample of 19 on Immune Modulation, published in Cells (2021) — summary generated from the PubMed abstract.
2021
Cells
9 citations
n = 19
Level AMeta-analysisPubMed
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Meta-analysis with a reported sample of 117 on Systemic / IV, published in Stem Cells Transl Med (2020) — summary generated from the PubMed abstract.
2020
Stem Cells Transl Med
n = 117
Level CProspective StudyPubMed
Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.
Prospective Study with a reported sample of 7 on Systemic / IV, published in Aging Dis (2020) — summary generated from the PubMed abstract.
2020
Aging Dis
53 citations
n = 7
Level DNarrative ReviewPubMed
Cellular Therapy: Shafts of Light Emerging for COVID-19.
Narrative Review with a reported sample of 19 on Immune Modulation, published in Stem Cell Investig (2020) — summary generated from the PubMed abstract.
2020
Stem Cell Investig
9 citations
n = 19
Level BClinical TrialEurope PMC
Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials
Clinical Trial, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
2020
World J Stem Cells
17 citations
Level ASystematic ReviewEurope PMC
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19
Systematic Review with a reported sample of 19 on Systemic / IV, published in Life Sci (2020) — summary generated from the PubMed abstract.
2020
Life Sci
62 citations
n = 19
Level BClinical TrialEurope PMC
Stem cell therapy for COVID-19: Possibilities and challenges
Clinical Trial with a reported sample of 19, published in Cell Biol Int (2020) — summary generated from the PubMed abstract.
2020
Cell Biol Int
38 citations
n = 19
Level DNarrative ReviewEurope PMC
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Narrative Review on Immune Modulation, Autoimmune Research, published in Hum Cell (2020) — summary generated from the PubMed abstract.
2020
Hum Cell
59 citations

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Stem cell therapy alleviates hair loss caused by COVID-19 vaccination

Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19

The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy

Systematic review: Impact of stem cells-based therapy, and platelet-rich plasma in hair loss and telogen effluvium related to COVID-19.

Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program.

Potential for Stem Cell-Based Therapy in the Road of Treatment for Neurological Disorders Secondary to COVID-19

Stem cell therapy for COVID-19 pneumonia

Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms

Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends

Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review

Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19

Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis.

Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review

Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update

Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury

Stem cell-based therapy for COVID-19 and ARDS: a systematic review

Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.

Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease.

Cellular Therapy: Shafts of Light Emerging for COVID-19.

Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials

The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19

Stem cell therapy for COVID-19: Possibilities and challenges

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis